tiprankstipranks
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market
Holding LYRA?
Track your performance easily

Lyra Therapeutics (LYRA) Financial Statements

266 Followers

Lyra Therapeutics Financial Overview

Lyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.532; its P/E ratio is -0.12; Lyra Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 195.00K$ 598.00K$ 532.00K$ 146.00K$ 544.00K
Gross Profit$ 195.00K$ 598.00K$ 532.00K$ 146.00K$ 544.00K
EBIT$ -11.87M$ -48.12M$ -22.44M$ -16.48M$ -16.83M
EBITDA$ -11.83M$ -47.04M$ -23.23M$ -16.39M$ -16.83M
Net Income Common Stockholders$ -11.87M$ -48.13M$ -22.45M$ -15.16M$ -15.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.60M$ 67.50M$ 87.10M$ 102.75M$ 102.55M
Total Assets$ 78.76M$ 94.58M$ 141.53M$ 142.60M$ 120.58M
Total Debt$ 35.32M$ 36.75M$ 37.86M$ 26.88M$ 6.29M
Net Debt$ -16.28M$ -30.76M$ -49.24M$ -75.87M$ -96.26M
Total Liabilities$ 58.14M$ 63.60M$ 64.02M$ 53.18M$ 36.34M
Stockholders Equity$ 20.62M$ 30.98M$ 77.50M$ 89.42M$ 84.24M
Cash Flow-
Free Cash Flow$ -16.27M$ -20.18M$ -24.60M$ -19.84M$ -14.26M
Operating Cash Flow$ -16.22M$ -19.98M$ -22.45M$ -19.06M$ -14.11M
Investing Cash Flow$ 8.14M$ 36.18M$ 7.86M$ -2.36M$ -14.98M
Financing Cash Flow$ -23.00K$ -89.00K$ 8.64M$ 18.92M$ -418.00K
Currency in USD

Lyra Therapeutics Earnings and Revenue History

Lyra Therapeutics Debt to Assets

Lyra Therapeutics Cash Flow

Lyra Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis